Genitourinary Cancer

Genitourinary Cancer

Recently Added |View More

Don’t Miss Roswell Park at AUA News

Don’t Miss Roswell Park at AUA

Roswell Park Comprehensive Cancer Center is proud to highlight seven experts who will be presenting their new research at this year’s Annual Meeting of the American Urological Association, May 15-16 in Washington, DC.

Roswell Park Study: Inhibiting Regulator Protein Can Make Aggressive Prostate Cancers More Vulnerable News

Roswell Park Study: Inhibiting Regulator Protein Can Make Aggressive Prostate Cancers More Vulnerable

Team shows BCL-2 promotes treatment resistance, uncovering strategy for making tumors respond to treatment.

Can Genetic Testing Identify the Best Treatment for Metastatic, Castration-Resistant Prostate Cancer? News

Can Genetic Testing Identify the Best Treatment for Metastatic, Castration-Resistant Prostate Cancer?

Patients with metastatic, castration-resistant prostate cancer (mCRPC) have a median overall survival of only about two to three years, but genomic sequencing is making inroads against that grim prognosis.

Join Roswell Park Expert at 2nd Annual Upstate Cancer Symposium June 21 Document

Join Roswell Park Expert at 2nd Annual Upstate Cancer Symposium June 21

The Oncology Brothers, including Roswell Park Comprehensive Cancer Center’s Rohit Gosain, MD, are hosting the second annual Upstate Cancer Symposium in Buffalo on June 21.

Roswell Park is Hiring! News

Roswell Park is Hiring!

Working at Roswell Park will afford you incredible opportunities to work alongside some of the nation’s foremost clinicians and researchers to broaden your career experiences and be part of a team that eases the burden of cancer.

Roswell Park Researchers to Discuss Recent Discoveries and Critical Issues in Oncology at AACR 2025 News

Roswell Park Researchers to Discuss Recent Discoveries and Critical Issues in Oncology at AACR 2025

Researchers from Roswell Park Comprehensive Cancer Center will report their latest findings to colleagues from around the world at the 2025 annual meeting of the American Association for Cancer Research (AACR) in Chicago, Illinois, April 25-30.

Join Roswell Park's Experts at NCCN News

Join Roswell Park's Experts at NCCN

Roswell Park invites you to meet some of our leading experts in oncology and patient care at the National Comprehensive Cancer Network's 2025 Annual Meeting in Orlando, FL, on March 28-30.

Join Roswell Park’s Surgical Experts at SSO News

Join Roswell Park’s Surgical Experts at SSO

Meet some of our leading surgical oncology experts at this year's Society of Surgical Oncology Annual Meeting in Phoenix, AZ, on March 5-7.

Clinical Trial Evaluates Promising Treatment Combination for Patients with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma News

Clinical Trial Evaluates Promising Treatment Combination for Patients with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma

Phase 3 clinical trial is underway, it will evaluate the potential of combining an investigational drug, the targeted therapy XL092 (brand name Zanzalintinib), with the FDA-approved immunotherapy nivolumab (brand name Opdivo).

This site is intended for healthcare professionals

RPMD App
Access wherever you go

Click your preferred app store below to download our free mobile app — exclusively for physicians and physician offices — for direct access to a complete, up-to-date directory of Roswell Park physicians wherever you go. Email or call to refer a patient or ask a question with a click of a button.